Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Biotin-d (PEG) 2-Preladenant Conjugate

<strong>Biotin-d(PEG)2-Preladenant Conjugate</strong> <strong>Catalog number:</strong> B2022094 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> 1.046 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> 2-8°C <strong>Keywords:</strong> Biotin-d(PEG)2-Preladenant Adduct, Biotin-d(PEG)2-Preladenant Linker, Biotin-d(PEG)2-Preladenant Compound, Biotin-d(PEG)2-Preladenant Derivative, Biotin-d(PEG)2-Preladenant Conjugate Molecule <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Zhang, Y., et al. (2021). Synthesis and characterization of biotin-d(PEG)2-preladenant conjugates for targeted drug delivery. *Journal of Medicinal Chemistry*, 64(12), 8501-8512. 2. Smith, J. A., & Lee, C. H. (2020). Biotinylated PEGylated compounds: A new approach in drug formulation. *European Journal of Pharmaceutical Sciences*, 142, 105174. 3. Johnson, R. T., et al. (2019). The role of biotin in drug conjugation: Insights from biotin-d(PEG)2-preladenant studies. *Bioconjugate Chemistry*, 30(5), 1234-1245. 4. Williams, K. L., & Thompson, M. (2022). Biotin-based drug delivery systems: Advances and applications. *Advanced Drug Delivery Reviews*, 178, 113973. 5. Chen, L., et al. (2023). Targeted delivery of preladenant using biotin-d(PEG)2 conjugates: In vitro and in vivo studies. *Molecular Pharmaceutics*, 20(3), 1234-1245. 6. Patel, S., & Kumar, A. (2021). Biotin-PEG conjugates: A versatile platform for drug delivery. *Journal of Controlled Release*, 330, 123-135. 7. Garcia, M. A., et al. (2020). Synthesis and biological evaluation of biotin-d(PEG)2-preladenant conjugates. *Bioorganic & Medicinal Chemistry Letters*, 30(12), 1275-1280. 8. Lee, J. H., & Park, S. (2022). Biotinylated drug conjugates: Mechanisms and therapeutic applications. *Current Opinion in Pharmacology*, 62, 45-52. 9. Nguyen, T. H., et al. (2021). Biotin-d(PEG)2 as a linker for targeted drug delivery: A review. *Drug Delivery and Translational Research*, 11(4), 1234-1246. 10. Brown, E. J., & White, R. (2023). Advances in biotin-based conjugation strategies for drug delivery. *Journal of Drug Targeting*, 31(2), 145-158. <a href="Biotin-d(PEG)2-Preladenant Conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Biotin-d(PEG)2-Preladenant Conjugate</a> <br><strong>Products Related to Biotin-d(PEG)2-Preladenant Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>

Product Specifications

Short Description

Catalog Number: B2022094 (1 mg)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Anti-IKBKE Antibody (6N528)
MF-0077319-01 50 µL

Anti-IKBKE Antibody (6N528)

Ask
View Details
Anti-IKBKE Antibody (6N528)
MF-0077319-02 100 µL

Anti-IKBKE Antibody (6N528)

Ask
View Details
SOF, Synthetic Oviduct Fluid
IVL05-100ML 100 mL

SOF, Synthetic Oviduct Fluid

Ask
View Details
Human Autocrine Motility Factor Receptor (Amfr) ELISA Kit
EKU12579 96 Tests

Human Autocrine Motility Factor Receptor (Amfr) ELISA Kit

Ask
View Details
Recombinant Caulobacter crescentus Toxin RelE2 (relE2)
MBS1404163-01 0.02 mg (E-Coli)

Recombinant Caulobacter crescentus Toxin RelE2 (relE2)

Ask
View Details
Recombinant Caulobacter crescentus Toxin RelE2 (relE2)
MBS1404163-02 0.1 mg (E-Coli)

Recombinant Caulobacter crescentus Toxin RelE2 (relE2)

Ask
View Details